PubRank

Andrew J Peat

Author PubWeight™ 9.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol 2006 2.62
2 Synthesis and activity of small molecule GPR40 agonists. Bioorg Med Chem Lett 2006 1.12
3 Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3. Bioorg Med Chem Lett 2006 1.11
4 Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor. Bioorg Med Chem Lett 2007 0.92
5 Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1. J Med Chem 2006 0.86
6 Hepatitis C replication inhibitors that target the viral NS4B protein. J Med Chem 2013 0.83
7 Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase. J Med Chem 2013 0.78
8 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist. J Med Chem 2006 0.77
9 The discovery and optimization of pyrimidinone-containing MCH R1 antagonists. Bioorg Med Chem Lett 2006 0.76
10 Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups. Bioorg Med Chem Lett 2008 0.75
11 Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues. Bioorg Med Chem Lett 2008 0.75
12 Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy. Bioorg Med Chem Lett 2008 0.75